Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Muscle Synergy-Inspired Functional Electrical Stimulation for Rehabilitating Hand Motor Functions Post-Stroke

13 novembre 2026 aggiornato da: Cheung Chi Kwan Vincent, Chinese University of Hong Kong

The goal of this clinical trial is to learn whether muscle-synergy-based functional electrical stimulation works to improve upper limb motor function in stroke subjects. The main questions it aims to answer are:

Does muscle-synergy inspired FES strategy help participant get better motor recovery?

Participants will:

Receive FES or sham stimulation to the affected arm for 30 minutes a day, for 5 sessions.

Continue their usual rehabilitation programme throughout the study. Record clinical assessments and high-density EMGs before and after the treatment.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Unilateral stroke survivors (N=50) will be recruited and randomly assigned to one of two groups, which will receive usual rehabilitation care only, and usual care plus functional electrical stimulation (FES) training, respectively. Each subject will be evaluated before (T0), after (T1) intervention. At T0, clinical scores (Fugl-Meyer assessment, Brunnstrom stage), video recordings of hand movement, and high-density EMGs will be applied on the patients' forearm to assess the motor functions. At T1, clinical scores, video recordings, and high-density EMGs will be assessed again for characterizing post-rehab functional gain and recovery. Treatments will last ≥5 training sessions depending on the inpatient stay days. All T0 and T1 data will be analyzed offline with muscle synergy analysis and motor unit decomposition analysis.

Clinical scores. Clinical assessments will be conducted at both T0 and T1 to characterize upper extremity motor impairment and evaluate changes in motor recovery between the two assessment time points. Two complementary clinical measures will be used: (1) the Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and (2) the Brunnstrom Stages of Motor Recovery.

The FMA-UE will be used to quantify motor impairment of the affected upper extremity. It assesses reflex activity, voluntary movements within and outside synergistic patterns, wrist and hand motor function, and coordination and movement speed. The motor score ranges from 0 to 66, with higher scores indicating less severe motor impairment. This assessment provides a structured characterization of residual motor abilities and difficulties in selective movement control and is widely used in clinical stroke rehabilitation. Changes in FMA-UE scores between T0 and T1 will be used to quantify changes in upper extremity motor impairment.

The Brunnstrom Stages will be used to characterize the stage of motor recovery following stroke. This assessment describes recovery patterns ranging from flaccidity and limited voluntary movement to the emergence of synergistic movements and, subsequently, more selective and coordinated voluntary control. It complements the FMA-UE by providing an ordinal classification of motor recovery, with particular emphasis on the presence of abnormal synergies and the ability to perform movements independently of these patterns. Comparisons between T0 and T1 will indicate whether participants have progressed to a more advanced recovery stage.

The two assessments are expected to take approximately 30 minutes in total at each time point. Participants' basic demographic characteristics, comorbidities, and other relevant medical conditions will be retrieved from their medical records to characterize the study population and provide clinical context for interpreting the assessment results.

Hand Kinematics recording. Hand kinematic recording. Hand kinematics will be assessed at T0 and T1 using a markerless, multi-camera recording system to quantify extension performance and selective finger control under FES-on and FES-off conditions. The emphasis on extension is motivated by the prognostic relevance of early voluntary finger extension for subsequent upper limb recovery after stroke (Nijland et al., 2010). Extension performance and finger individuation will be evaluated separately, as strength and selective finger control represent distinguishable dimensions of post-stroke hand recovery (Xu et al., 2017). Previous studies have demonstrated the feasibility of video-based markerless assessment of finger movements and upper limb reaching in individuals with stroke (Choudhury et al., 2025; Suwabe et al., 2024).

Participants will be seated comfortably, with the affected forearm supported in pronation, the palm facing downward, and the hand initially in a relaxed resting posture. The support will be arranged to allow unrestricted finger and wrist extension. The initial wrist and finger positions will be documented before each trial, and the forearm position and support configuration will be reproduced across conditions and assessment sessions. Following a standardized verbal cue, participants will perform five tasks: (1) simultaneous extension of all five digits to open the hand; (2) selective thumb extension; (3) selective index finger extension; (4) simultaneous extension of the middle, ring, and little fingers; and (5) wrist extension. Participants will attempt to maintain the achieved position for 5 s before returning to the resting posture. During tasks 2-4, they will be instructed to keep the non-target digits as still as possible without external restraint. During finger tasks, participants will also be instructed to minimize wrist movement and forearm rotation. Each task will be repeated five times per condition, with rest periods between trials to limit fatigue. Condition order will be counterbalanced across participants.

Three USB cameras will be positioned at complementary angles around the hand, with each camera configured to acquire video at 1280 × 720 pixels, in YUYV format, at 60 frames per second. OBS Studio will control recording initiation and termination, and the three camera feeds will be recorded within a single scene using a fixed layout that preserves the native resolution of each view. Camera positions, focus, and lighting will remain unchanged during calibration and task recording. Intrinsic and extrinsic camera parameters will be estimated using a calibration board of known dimensions. Inter-camera timing offsets and temporal stability will be checked using a visual timing signal visible in all views, because simultaneous recording within an OBS scene does not establish hardware synchronization. Stimulation onset and offset will be documented relative to the video timeline.

Offline processing will combine DeepLabCut for two-dimensional landmark detection with Anipose for three-dimensional reconstruction (Karashchuk et al., 2021; Mathis et al., 2018). Composite videos will be separated into individual camera views using fixed crop coordinates, with identical processing applied to calibration recordings. A DeepLabCut model will be trained or fine-tuned using annotated frames covering different participants, hand postures, camera views, and stimulation conditions. Landmarks on the forearm, wrist, hand, and digits will be tracked, and temporally aligned detections will be triangulated using Anipose. Joint angles and digit movements will be calculated relative to anatomical segment coordinate systems to reduce the influence of whole-hand translation and rotation. Tracking accuracy will be evaluated using held-out annotated frames, reprojection errors, and visual inspection. Filtering, short-gap interpolation, and exclusion criteria will be specified before outcome analysis.

Kinematic outcomes will include joint extension excursion, peak extension velocity, maximum continuous holding duration, and unintended movement of non-target digits. Extension task success will be defined as reaching the prespecified task-specific joint-angle targets within the allowed response period and maintaining them continuously for 5 s without prohibited assistance or compensatory movement. For tasks 2-4, selective extension success will additionally require non-target digit movements to remain within predefined tolerances throughout the movement and holding phases. Target angles, response periods, and movement tolerances will be established through pilot testing, considering measurement error, passive range of motion, and physiological finger coupling, and will be fixed before the main study (Lang and Schieber, 2004). Task success rates will be calculated separately for each task and condition as the number of successful trials divided by the number of assessable trials, multiplied by 100%. Unsuccessful movement attempts will remain in the denominator, whereas technically unassessable trials will be documented separately. FES-on versus FES-off comparisons will characterize immediate stimulation-assisted performance, while changes in FES-off performance between T0 and T1 will characterize changes in voluntary motor performance.

High-density EMGs recording. High-density surface electromyography (HD-sEMG) will be recorded at T0 and T1 to characterize forearm muscle activity during voluntary hand and wrist movements without FES. HD-sEMG enables the assessment of the spatial distribution of muscle electrical activity across the skin surface (Gallina et al., 2022). Signals will be acquired using a TMSi recording system at a sampling rate of 2048 Hz, synchronized with the three-camera kinematic recording system.

Two customized flexible electrode arrays will be positioned around the middle third of the affected forearm. Each array will contain 64 recording channels arranged into eight longitudinal electrode columns (threads), with eight electrodes per thread and a longitudinal interelectrode spacing of 1 cm. Channels 1-64 will cover the palmar aspect of the forearm, while channels 65-128 will cover the dorsal aspect, providing 128 recording channels distributed across 16 threads around the forearm circumference. The spacing between adjacent threads will vary according to forearm circumference. A measuring tape will guide placement to distribute the threads as evenly as possible, and the position of the first thread will be marked on the skin to guide consistent array alignment across assessments.

During recording, participants will be seated with the affected forearm supported in pronation, the palm facing downward, and the hand initially in a relaxed resting posture. Participants will perform five tasks in a fixed sequence: (1) simultaneous extension of all five digits; (2) selective thumb extension; (3) selective index finger extension; (4) simultaneous extension of the middle, ring, and little fingers; and (5) wrist extension. For each task, participants will attempt to maintain the achieved position for 5 s before returning to the resting posture. During selective digit tasks, participants will be instructed to minimize movement of the non-target digits without external restraint. The five-task sequence will be repeated eight times, yielding eight trials per task and 40 trials per assessment session. This predictable sequence is intended to reduce cognitive demands and distribute repetitions of each task across the recording session rather than requiring consecutive repetitions of the same movement. EMG and video recordings will include unsuccessful movement attempts as well as successfully completed trials.

Tipo di studio

Interventistico

Iscrizione (Stimato)

50

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Guangdong
      • Guangzhou, Guangdong, Cina
        • Reclutamento
        • Guangdong Work Injury Rehabilitation Hospital
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 80 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Unilateral stroke
  • Normal Cognition

Exclusion Criteria:

  • Bilateral stroke
  • Upper limb injury

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Apply personalized functional electrical stimulation based on high-density EMG assessment

Apply personalized functional electrical stimulation to upper limb of stroke patients

Comparatore fittizio: Apply functional electrical stimulation that targets dorsal forearm

Apply personalized functional electrical stimulation to upper limb of stroke patients

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Fugl-Meyer assessment - upper extremity
Lasso di tempo: Two weeks

Two-stage of assessment including pre-assessment and post-assessment

Two weeks
High-density EMG assessment
Lasso di tempo: two weeks

High-density EMG assessment

two weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Vincent Cheung, Doctor of Philosophy, The Chinese University of Hong Kong, Gerald Choa Neuroscience Institute

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

16 novembre 2026

Completamento primario (Stimato)

30 dicembre 2027

Completamento dello studio (Stimato)

15 aprile 2028

Date di iscrizione allo studio

Primo inviato

13 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • FES_HDEMG_UE_V1
  • GHP/166/23SZ (Altro identificatore: Innovation and Technology Commission, Hong Kong)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .